Search by Drug Name or NDC

    NDC 00409-3510-22 Ertapenem 1 g/1 Details

    Ertapenem 1 g/1

    Ertapenem is a INTRAMUSCULAR; INTRAVENOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is ERTAPENEM SODIUM.

    Product Information

    NDC 00409-3510
    Product ID 0409-3510_3b435e53-f4bc-44d5-8995-797afb41c1ae
    Associated GPIs 16150030102130
    GCN Sequence Number 049835
    GCN Sequence Number Description ertapenem sodium VIAL 1 G INJECTION
    HIC3 W1S
    HIC3 Description CARBAPENEM ANTIBIOTICS (THIENAMYCINS)
    GCN 15527
    HICL Sequence Number 023241
    HICL Sequence Number Description ERTAPENEM SODIUM
    Brand/Generic Generic
    Proprietary Name Ertapenem
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ertapenem
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAMUSCULAR; INTRAVENOUS
    Active Ingredient Strength 1
    Active Ingredient Units g/1
    Substance Name ERTAPENEM SODIUM
    Labeler Name Hospira, Inc.
    Pharmaceutical Class Carbapenems [CS], Penem Antibacterial [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA208790
    Listing Certified Through 2024-12-31

    Package

    NDC 00409-3510-22 (00409351022)

    NDC Package Code 0409-3510-22
    Billing NDC 00409351022
    Package 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3510-22) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE (0409-3510-21)
    Marketing Start Date 2020-10-19
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 42.9888
    Pricing Unit EA
    Effective Date 2023-11-22
    NDC Description ERTAPENEM 1 GRAM VIAL
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4, 5
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis